nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Estropipate—osteoporosis	0.392	0.707	CbGbCtD
Gadobenate Dimeglumine—ALB—Estradiol—osteoporosis	0.163	0.293	CbGbCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—WDR1—osteoporosis	0.000346	0.0441	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.00033	0.042	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.000329	0.0419	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Lipoprotein metabolism—P4HB—osteoporosis	0.000324	0.0412	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.000317	0.0403	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Estropipate—osteoporosis	0.000288	0.000658	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Estradiol—osteoporosis	0.000288	0.000658	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Zoledronate—osteoporosis	0.000288	0.000657	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Zoledronate—osteoporosis	0.000288	0.000657	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Zoledronate—osteoporosis	0.000288	0.000657	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Conjugated Estrogens—osteoporosis	0.000288	0.000657	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Zoledronate—osteoporosis	0.000287	0.000655	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000286	0.000653	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000286	0.000652	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Risedronate—osteoporosis	0.000285	0.000651	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Estropipate—osteoporosis	0.000284	0.000649	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Zoledronate—osteoporosis	0.000284	0.000649	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Alendronate—osteoporosis	0.000284	0.000649	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Ibandronate—osteoporosis	0.000284	0.000648	CcSEcCtD
Gadobenate Dimeglumine—Cough—Conjugated Estrogens—osteoporosis	0.000284	0.000648	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Risedronate—osteoporosis	0.000283	0.000647	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Pamidronate—osteoporosis	0.000282	0.000644	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Zoledronate—osteoporosis	0.000281	0.000642	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000281	0.000642	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000281	0.000641	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Alendronate—osteoporosis	0.00028	0.000639	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Risedronate—osteoporosis	0.00028	0.000638	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Estradiol—osteoporosis	0.00028	0.000638	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Estradiol—osteoporosis	0.000279	0.000637	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Ethinyl Estradiol—osteoporosis	0.000279	0.000636	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Zoledronate—osteoporosis	0.000278	0.000635	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Calcitriol—osteoporosis	0.000278	0.000635	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Estradiol—osteoporosis	0.000278	0.000634	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Estradiol—osteoporosis	0.000278	0.000634	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Conjugated Estrogens—osteoporosis	0.000277	0.000633	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Conjugated Estrogens—osteoporosis	0.000277	0.000633	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000277	0.000633	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Ibandronate—osteoporosis	0.000277	0.000631	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Conjugated Estrogens—osteoporosis	0.000276	0.00063	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Etidronic acid—osteoporosis	0.000276	0.00063	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Zoledronate—osteoporosis	0.000276	0.00063	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000275	0.000628	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000275	0.000628	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Estropipate—osteoporosis	0.000275	0.000628	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000274	0.000626	CcSEcCtD
Gadobenate Dimeglumine—Infection—Zoledronate—osteoporosis	0.000274	0.000626	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Risedronate—osteoporosis	0.000274	0.000625	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—CAP1—osteoporosis	0.000274	0.0348	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Ibandronate—osteoporosis	0.000273	0.000623	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Risedronate—osteoporosis	0.000272	0.00062	CcSEcCtD
Gadobenate Dimeglumine—Pain—Risedronate—osteoporosis	0.000272	0.00062	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Estradiol—osteoporosis	0.000271	0.00062	CcSEcCtD
Gadobenate Dimeglumine—Shock—Zoledronate—osteoporosis	0.000271	0.00062	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Pamidronate—osteoporosis	0.000271	0.000619	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Alendronate—osteoporosis	0.000271	0.000618	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Calcitriol—osteoporosis	0.000271	0.000618	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Zoledronate—osteoporosis	0.00027	0.000618	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Estradiol—osteoporosis	0.00027	0.000617	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Estradiol—osteoporosis	0.00027	0.000616	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Pamidronate—osteoporosis	0.000269	0.000615	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Zoledronate—osteoporosis	0.000269	0.000615	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000268	0.000613	CcSEcCtD
Gadobenate Dimeglumine—Chills—Estradiol—osteoporosis	0.000268	0.000613	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Pamidronate—osteoporosis	0.000268	0.000613	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Zoledronate—osteoporosis	0.000268	0.000612	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Calcitriol—osteoporosis	0.000267	0.000609	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Zoledronate—osteoporosis	0.000267	0.000609	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000266	0.000608	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Raloxifene—osteoporosis	0.000266	0.000608	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Pamidronate—osteoporosis	0.000266	0.000607	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Estropipate—osteoporosis	0.000266	0.000607	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000266	0.0338	CbGpPWpGaD
Gadobenate Dimeglumine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000266	0.000606	CcSEcCtD
Gadobenate Dimeglumine—Infection—Conjugated Estrogens—osteoporosis	0.000264	0.000602	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Ibandronate—osteoporosis	0.000264	0.000602	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Estradiol—osteoporosis	0.000262	0.000598	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Alendronate—osteoporosis	0.000262	0.000598	CcSEcCtD
Gadobenate Dimeglumine—Shock—Conjugated Estrogens—osteoporosis	0.000261	0.000597	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000261	0.000595	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.000261	0.0332	CbGpPWpGaD
Gadobenate Dimeglumine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00026	0.000595	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Estradiol—osteoporosis	0.00026	0.000595	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Estradiol—osteoporosis	0.00026	0.000595	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Pamidronate—osteoporosis	0.00026	0.000594	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Risedronate—osteoporosis	0.00026	0.000593	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000259	0.000592	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000259	0.000591	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Pamidronate—osteoporosis	0.000258	0.00059	CcSEcCtD
Gadobenate Dimeglumine—Pain—Pamidronate—osteoporosis	0.000258	0.00059	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Calcitriol—osteoporosis	0.000258	0.000589	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000258	0.000589	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Zoledronate—osteoporosis	0.000258	0.000588	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000258	0.000588	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000258	0.000588	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Raloxifene—osteoporosis	0.000257	0.000588	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000257	0.000586	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Estropipate—osteoporosis	0.000256	0.000583	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Estradiol—osteoporosis	0.000255	0.000582	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Ibandronate—osteoporosis	0.000255	0.000582	CcSEcCtD
Gadobenate Dimeglumine—Rash—Estropipate—osteoporosis	0.000253	0.000579	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Estropipate—osteoporosis	0.000253	0.000578	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Risedronate—osteoporosis	0.000252	0.000576	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Estradiol—osteoporosis	0.000252	0.000575	CcSEcCtD
Gadobenate Dimeglumine—Headache—Estropipate—osteoporosis	0.000252	0.000575	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Alendronate—osteoporosis	0.000252	0.000575	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000251	0.000574	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Risedronate—osteoporosis	0.000251	0.000573	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Risedronate—osteoporosis	0.000251	0.000573	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Estradiol—osteoporosis	0.00025	0.000572	CcSEcCtD
Gadobenate Dimeglumine—Rash—Alendronate—osteoporosis	0.00025	0.00057	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Alendronate—osteoporosis	0.000249	0.000569	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Pamidronate—osteoporosis	0.000249	0.000568	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Conjugated Estrogens—osteoporosis	0.000248	0.000567	CcSEcCtD
Gadobenate Dimeglumine—Headache—Alendronate—osteoporosis	0.000248	0.000566	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Zoledronate—osteoporosis	0.000248	0.000565	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Raloxifene—osteoporosis	0.000248	0.000565	CcSEcCtD
Gadobenate Dimeglumine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	0.000248	0.0315	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000247	0.000564	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Zoledronate—osteoporosis	0.000246	0.000561	CcSEcCtD
Gadobenate Dimeglumine—Rash—Raloxifene—osteoporosis	0.000245	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Raloxifene—osteoporosis	0.000245	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Zoledronate—osteoporosis	0.000245	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Ibandronate—osteoporosis	0.000245	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Estradiol—osteoporosis	0.000244	0.000557	CcSEcCtD
Gadobenate Dimeglumine—Headache—Raloxifene—osteoporosis	0.000244	0.000557	CcSEcCtD
Gadobenate Dimeglumine—Rash—Ibandronate—osteoporosis	0.000243	0.000555	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Ibandronate—osteoporosis	0.000243	0.000554	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Zoledronate—osteoporosis	0.000243	0.000554	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000242	0.000552	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Estradiol—osteoporosis	0.000242	0.000552	CcSEcCtD
Gadobenate Dimeglumine—Headache—Ibandronate—osteoporosis	0.000241	0.000551	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00024	0.000548	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Calcitriol—osteoporosis	0.00024	0.000548	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Estropipate—osteoporosis	0.000239	0.000545	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Pamidronate—osteoporosis	0.000239	0.000545	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Pamidronate—osteoporosis	0.000239	0.000545	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000238	0.000544	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000238	0.000544	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Estradiol—osteoporosis	0.000238	0.000543	CcSEcCtD
Gadobenate Dimeglumine—Rash—Calcitriol—osteoporosis	0.000238	0.000543	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Zoledronate—osteoporosis	0.000238	0.000543	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Calcitriol—osteoporosis	0.000238	0.000543	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000237	0.000541	CcSEcCtD
Gadobenate Dimeglumine—Headache—Calcitriol—osteoporosis	0.000236	0.00054	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Conjugated Estrogens—osteoporosis	0.000236	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Zoledronate—osteoporosis	0.000236	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Pain—Zoledronate—osteoporosis	0.000236	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Alendronate—osteoporosis	0.000235	0.000537	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Estradiol—osteoporosis	0.000235	0.000536	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Risedronate—osteoporosis	0.000234	0.000534	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000234	0.000534	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000234	0.000534	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Estradiol—osteoporosis	0.000234	0.000533	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Raloxifene—osteoporosis	0.000231	0.000528	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00023	0.000526	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Estradiol—osteoporosis	0.00023	0.000525	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000229	0.000524	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Conjugated Estrogens—osteoporosis	0.000229	0.000523	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Ibandronate—osteoporosis	0.000229	0.000523	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Estradiol—osteoporosis	0.000229	0.000523	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Risedronate—osteoporosis	0.000228	0.00052	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Zoledronate—osteoporosis	0.000227	0.000519	CcSEcCtD
Gadobenate Dimeglumine—Cough—Estradiol—osteoporosis	0.000227	0.000519	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Conjugated Estrogens—osteoporosis	0.000227	0.000519	CcSEcCtD
Gadobenate Dimeglumine—Pain—Conjugated Estrogens—osteoporosis	0.000227	0.000519	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000226	0.000515	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Estradiol—osteoporosis	0.000225	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Risedronate—osteoporosis	0.000225	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Calcitriol—osteoporosis	0.000224	0.000512	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000223	0.000509	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Pamidronate—osteoporosis	0.000222	0.000508	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Estradiol—osteoporosis	0.000222	0.000506	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Estradiol—osteoporosis	0.000222	0.000506	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Estradiol—osteoporosis	0.000222	0.000506	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Estradiol—osteoporosis	0.000221	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00022	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Zoledronate—osteoporosis	0.000219	0.0005	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Estradiol—osteoporosis	0.000219	0.0005	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Zoledronate—osteoporosis	0.000218	0.000498	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Zoledronate—osteoporosis	0.000218	0.000498	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Risedronate—osteoporosis	0.000217	0.000496	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000217	0.000496	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Estradiol—osteoporosis	0.000217	0.000495	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Pamidronate—osteoporosis	0.000217	0.000495	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000215	0.000492	CcSEcCtD
Gadobenate Dimeglumine—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.000215	0.0274	CbGpPWpGaD
Gadobenate Dimeglumine—Confusional state—Estradiol—osteoporosis	0.000214	0.000489	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Pamidronate—osteoporosis	0.000214	0.000488	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Estradiol—osteoporosis	0.000213	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Infection—Estradiol—osteoporosis	0.000211	0.000482	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Conjugated Estrogens—osteoporosis	0.000211	0.000482	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Risedronate—osteoporosis	0.00021	0.00048	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00021	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00021	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Shock—Estradiol—osteoporosis	0.000209	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Estradiol—osteoporosis	0.000208	0.000476	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Estradiol—osteoporosis	0.000207	0.000474	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000207	0.000473	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Pamidronate—osteoporosis	0.000207	0.000472	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Estradiol—osteoporosis	0.000206	0.000471	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Estradiol—osteoporosis	0.000205	0.000469	CcSEcCtD
Gadobenate Dimeglumine—Rash—Ethinyl Estradiol—osteoporosis	0.000205	0.000469	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000205	0.000469	CcSEcCtD
Gadobenate Dimeglumine—Headache—Ethinyl Estradiol—osteoporosis	0.000204	0.000466	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Zoledronate—osteoporosis	0.000203	0.000464	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Risedronate—osteoporosis	0.000202	0.000461	CcSEcCtD
Gadobenate Dimeglumine—Rash—Risedronate—osteoporosis	0.0002	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Risedronate—osteoporosis	0.0002	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Pamidronate—osteoporosis	0.0002	0.000456	CcSEcCtD
Gadobenate Dimeglumine—Headache—Risedronate—osteoporosis	0.000199	0.000454	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—PLEK—osteoporosis	0.000199	0.0253	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Zoledronate—osteoporosis	0.000198	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000196	0.000447	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Zoledronate—osteoporosis	0.000195	0.000446	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000194	0.000442	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Ethinyl Estradiol—osteoporosis	0.000194	0.000442	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Pamidronate—osteoporosis	0.000192	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Estradiol—osteoporosis	0.000191	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Conjugated Estrogens—osteoporosis	0.000191	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Rash—Pamidronate—osteoporosis	0.00019	0.000435	CcSEcCtD
Gadobenate Dimeglumine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.00019	0.0242	CbGpPWpGaD
Gadobenate Dimeglumine—Dermatitis—Pamidronate—osteoporosis	0.00019	0.000434	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Estradiol—osteoporosis	0.000189	0.000433	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000189	0.0241	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Pamidronate—osteoporosis	0.000189	0.000432	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Estradiol—osteoporosis	0.000189	0.000431	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Zoledronate—osteoporosis	0.000189	0.000431	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Risedronate—osteoporosis	0.000189	0.000431	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Conjugated Estrogens—osteoporosis	0.000188	0.000429	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Estradiol—osteoporosis	0.000187	0.000427	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000183	0.000419	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Estradiol—osteoporosis	0.000183	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Zoledronate—osteoporosis	0.000182	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Pain—Estradiol—osteoporosis	0.000182	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Estradiol—osteoporosis	0.000182	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000182	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Pamidronate—osteoporosis	0.000179	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Conjugated Estrogens—osteoporosis	0.000176	0.000401	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Zoledronate—osteoporosis	0.000175	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Estradiol—osteoporosis	0.000175	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Rash—Zoledronate—osteoporosis	0.000174	0.000397	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Estradiol—osteoporosis	0.000174	0.000397	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Zoledronate—osteoporosis	0.000174	0.000397	CcSEcCtD
Gadobenate Dimeglumine—Headache—Zoledronate—osteoporosis	0.000173	0.000395	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—TLN1—osteoporosis	0.000171	0.0218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—VCL—osteoporosis	0.000169	0.0215	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Conjugated Estrogens—osteoporosis	0.000169	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Estradiol—osteoporosis	0.000169	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Estradiol—osteoporosis	0.000168	0.000384	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Estradiol—osteoporosis	0.000168	0.000384	CcSEcCtD
Gadobenate Dimeglumine—Rash—Conjugated Estrogens—osteoporosis	0.000167	0.000382	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000167	0.000382	CcSEcCtD
Gadobenate Dimeglumine—Headache—Conjugated Estrogens—osteoporosis	0.000166	0.00038	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Zoledronate—osteoporosis	0.000164	0.000374	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000163	0.0208	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000161	0.0205	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Conjugated Estrogens—osteoporosis	0.000158	0.00036	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Estradiol—osteoporosis	0.000157	0.000358	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000154	0.0195	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Estradiol—osteoporosis	0.000152	0.000348	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Estradiol—osteoporosis	0.00015	0.000343	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Estradiol—osteoporosis	0.000145	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Estradiol—osteoporosis	0.000141	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Estradiol—osteoporosis	0.000135	0.000309	CcSEcCtD
Gadobenate Dimeglumine—Rash—Estradiol—osteoporosis	0.000134	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Estradiol—osteoporosis	0.000134	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Headache—Estradiol—osteoporosis	0.000133	0.000304	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—FGA—osteoporosis	0.000128	0.0163	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Estradiol—osteoporosis	0.000126	0.000288	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000122	0.0155	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000121	0.0155	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—FGB—osteoporosis	0.000117	0.0148	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000112	0.0142	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000111	0.0141	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	9.83e-05	0.0125	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	9.64e-05	0.0123	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—SOD2—osteoporosis	9.09e-05	0.0116	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	8.82e-05	0.0112	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—GPX1—osteoporosis	8.67e-05	0.011	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—MTHFR—osteoporosis	8e-05	0.0102	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—WDR1—osteoporosis	7.91e-05	0.0101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	7.6e-05	0.00968	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	7.5e-05	0.00955	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	7.22e-05	0.00919	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	6.89e-05	0.00877	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	6.35e-05	0.00809	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.3e-05	0.00802	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	6.26e-05	0.00798	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CAP1—osteoporosis	6.25e-05	0.00796	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.97e-05	0.0076	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	5.83e-05	0.00743	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	5.68e-05	0.00723	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—IGF1—osteoporosis	5.28e-05	0.00672	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	5.17e-05	0.00658	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	5.03e-05	0.0064	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MGLL—osteoporosis	4.97e-05	0.00633	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL1B—osteoporosis	4.75e-05	0.00605	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.64e-05	0.00591	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLEK—osteoporosis	4.54e-05	0.00579	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ANXA2—osteoporosis	4.54e-05	0.00579	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.52e-05	0.00576	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	4.23e-05	0.00539	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.93e-05	0.00501	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TLN1—osteoporosis	3.92e-05	0.00499	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—VCL—osteoporosis	3.86e-05	0.00492	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	3.77e-05	0.0048	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.62e-05	0.0046	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—TNF—osteoporosis	3.44e-05	0.00439	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	3.42e-05	0.00435	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—RAP1A—osteoporosis	3.23e-05	0.00411	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—TGFB1—osteoporosis	3.16e-05	0.00403	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.07e-05	0.00392	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	3.01e-05	0.00384	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—FGA—osteoporosis	2.93e-05	0.00373	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PKM—osteoporosis	2.8e-05	0.00357	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—FDPS—osteoporosis	2.8e-05	0.00357	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL6—osteoporosis	2.78e-05	0.00354	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—TNF—osteoporosis	2.74e-05	0.00348	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—FGB—osteoporosis	2.66e-05	0.00339	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PGLS—osteoporosis	2.66e-05	0.00338	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPD2—osteoporosis	2.66e-05	0.00338	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PNP—osteoporosis	2.43e-05	0.0031	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ATIC—osteoporosis	2.43e-05	0.0031	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.34e-05	0.00298	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.21e-05	0.00281	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—OXCT1—osteoporosis	2.07e-05	0.00263	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CA2—osteoporosis	2.07e-05	0.00263	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MGLL—osteoporosis	2.01e-05	0.00257	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.9e-05	0.00242	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—IDH2—osteoporosis	1.71e-05	0.00218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP27A1—osteoporosis	1.61e-05	0.00205	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ACP5—osteoporosis	1.57e-05	0.002	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.55e-05	0.00197	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.48e-05	0.00188	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—TPI1—osteoporosis	1.46e-05	0.00185	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.4e-05	0.00179	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—P4HB—osteoporosis	1.37e-05	0.00174	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GAPDH—osteoporosis	1.34e-05	0.00171	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—RAP1A—osteoporosis	1.31e-05	0.00167	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IGF1—osteoporosis	1.21e-05	0.00154	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.14e-05	0.00145	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ENO1—osteoporosis	1.06e-05	0.00135	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PSMA5—osteoporosis	1.04e-05	0.00133	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PSMA2—osteoporosis	1.04e-05	0.00133	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP19A1—osteoporosis	8.46e-06	0.00108	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TGFB1—osteoporosis	7.23e-06	0.000921	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ADCY5—osteoporosis	6.91e-06	0.00088	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPX1—osteoporosis	6.89e-06	0.000877	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MTHFR—osteoporosis	6.36e-06	0.00081	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—POMC—osteoporosis	5.08e-06	0.000647	CbGpPWpGaD
